Anthony Hilliard is a Cardiology physician. OpenAlex indexes 67 publications with 1,036 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11234 Anderson St
Loma Linda, CA 923542804
Telephone
909-558-4200Registry record last updated 8 Aug 2014.
Clinical trials
- Hand Injected Ventriculography vs. Power Injected Left Ventriculography
Sponsor: Loma Linda University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20258 payments
- Medtronic, Inc.Program year20251 payment
- ABIOMEDProgram year20247 payments$17,950openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.3%Beta blocker23.9%Metoprolol Succinate42%Metoprolol Tartrate33%Carvedilol25%Part D<11 patientsStatin16.3%Rosuvastatin Calcium73%Atorvastatin Calcium27%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
10.8%SGLT2 inhibitor6.4%Farxiga100%Part D<11 patientsBiguanide (metformin)4.4%Metformin Hcl100%Part D<11 patientsBlood & clotting
8.4%P2Y12 inhibitor8.4%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Navigating the Healthcare Conundrum: Leadership Perspective from a Premier Healthcare Organization in Loma Linda’s Blue Zone
Journal of Healthcare Leadership
2024 - Low dose oral minoxidil and the conundrum of cardiovascular complications
Dermatology Online Journal
2023 - A case report of myocardial infarction with non-obstructive coronary arteries as the initial presentation of eosinophilic granulomatosis with polyangiitis
European Heart Journal - Case Reports
2022
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”